The natriuretic peptides in the diagnosis of heart failure in primary care setting br

被引:0
|
作者
Turegano-Yedro, M. [1 ]
Ruiz-Garcia, A. [2 ]
Castillo-Moraga, M. J. [3 ]
Jimenez-Baena, E. [4 ]
Barrios, V [5 ]
Serrano-Cumplido, A. [6 ]
Pallares-Carratala, V [7 ,8 ]
机构
[1] Ctr Salud Aldea Moret, Med Familia & Comunitaria, Caceres, Spain
[2] Ctr Salud Univ Pinto, Med Familia & Comunitaria, Madrid, Spain
[3] Ctr Salud Sanlucar Barrio Bajo, Med Familia & Comunitaria, Cadiz, Spain
[4] Hosp Ciudad Coria, Serv Cardiol, Caceres, Spain
[5] Hosp Univ Ramon y Cajal, Serv Cardiol, Madrid, Spain
[6] Med Familia & Comunitaria, Getxo, Bizkaia, Spain
[7] Union Mutuas, Med Familia & Comunitaria, Unidad Vigilancia La Salud, Castellon de La Plana, Spain
[8] Univ Jaume 1, Dept Med, Castellon de La Plana, Spain
来源
MEDICINA DE FAMILIA-SEMERGEN | 2022年 / 48卷 / 07期
关键词
Heart failure; Diagnosis; Natriuretic peptides; Primary care; NT-PROBNP; CARDIOVASCULAR EVENTS; ATRIAL-FIBRILLATION; COST-EFFECTIVENESS; SOLUBLE ST2; BIOMARKERS; MORTALITY; RISK; ASSOCIATION; BNP;
D O I
10.1016/j.semerg.2022.101812
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Heart failure (HF) is a clinical syndrome characterized by symptoms and signs caused by structural and/or functional abnormalities of the heart that cause reduced cardiac output and/or elevated intracardiac pressures at rest or during exercise. Its prevalence and incidence are increasing and it is the leading cause of hospitalization in people over 65 years of age.The new American and European guidelines for the management of HF emphasize that the measurement of natriuretic peptide (NP) concentrations constitutes a cornerstone of the diag-nostic management of HF, and that the history, physical examination, electrocardiogram, and chest X-ray, complete the beginning of the HF diagnostic process. All these actions and diag-nostic tests can be performed and requested from the primary care office.The authors of this document, on behalf of the SEMERGEN Hypertension and Cardiovascu-lar Disease Working Group, have reviewed the most recent scientific evidence related to the preventive diagnostic management of NP in patients with HF in primary care setting.(c) 2022 Sociedad Espanola de Medicos de Atencion Primaria (SEMERGEN). Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Natriuretic Peptides in Heart Failure Atrial and B-type Natriuretic Peptides
    Maisel, Alan S.
    Duran, Jason M.
    Wettersten, Nicholas
    HEART FAILURE CLINICS, 2018, 14 (01) : 13 - +
  • [32] The multidimensional value of natriuretic peptides in heart failure, integrating laboratory and clinical aspects
    Gruson, Damien
    Hammerer-Lercher, Angelika
    Collinson, Paul
    Duff, Christopher
    Baum, Hannsjorg
    Pulkki, Kari
    Suvisaari, Janne
    Stankovic, Sanja
    Laitinen, Paivi
    Bayes-Genis, Antoni
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2024, 61 (06) : 458 - 472
  • [33] Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failure
    Singh, Shruti
    Pandey, Ambarish
    Neeland, Ian J.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2020, 63 (05) : 649 - 655
  • [34] Obese phenotype and natriuretic peptides in patients with heart failure with preserved ejection fraction
    Clerico, Aldo
    Zaninotto, Martina
    Passino, Claudio
    Plebani, Mario
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (07) : 1015 - 1025
  • [35] Natriuretic peptides and NGAL in heart failure: Does a link exist?
    Palazzuoli, Alberto
    Beltrami, Matteo
    Pellegrini, Marco
    Nuti, Ranuccio
    CLINICA CHIMICA ACTA, 2012, 413 (23-24) : 1832 - 1838
  • [36] Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
    Baba, Masako
    Yoshida, Kentaro
    Ieda, Masaki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (11)
  • [37] Natriuretic peptides revisited: new potentials and challenges in heart failure
    Farmakis, Dimitrios
    Parissis, John
    Papingiotis, George
    Lekakis, John
    Filippatos, Gerasimos
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (11) : 840 - 842
  • [38] Natriuretic peptides in heart failure: Current achievements and future perspectives
    Volpe, Massimo
    Battistoni, Allegra
    Rubattu, Speranza
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 281 : 186 - 189
  • [39] Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society
    Tsutsui, Hiroyuki
    Albert, Nancy M.
    Coats, Andrew J. S.
    Anker, Stefan D.
    Bayes-Genis, Antoni
    Butler, Javed
    Chioncel, Ovidiu
    Defilippi, Christopher R.
    Drazner, Mark H.
    Felker, G. Michael
    Filippatos, Gerasimos
    Fiuzat, Mona
    Ide, Tomomi
    Januzzi, James L., Jr.
    Kinugawa, Koichiro
    Kuwahara, Koichiro
    Matsue, Yuya
    Mentz, Robert J.
    Metra, Marco
    Pandey, Ambarish
    Rosano, Giuseppe
    Saito, Yoshihiko
    Sakata, Yasushi
    Sato, Naoki
    Seferovic, Petar M.
    Teerlink, John
    Yamamoto, Kazuhiro
    Yoshimura, Michihiro
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (05) : 616 - 631
  • [40] Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society
    Tsutsui, Hiroyuki
    Albert, Nancy M.
    Coats, Andrew J. S.
    Anker, Stefan D.
    Bayes-Genis, Antoni
    Butler, Javed
    Chioncel, Ovidiu
    Defilippi, Christopher R.
    Drazner, Mark H.
    Felker, G. Michael
    Filippatos, Gerasimos
    Fiuzat, Mona
    Ide, Tomomi
    Januzzi Jr, James L.
    Kinugawa, Koichiro
    Kuwahara, Koichiro
    Matsue, Yuya
    Mentz, Robertj
    Metra, Marco
    Pandey, Ambarish
    Rosano, Giuseppe
    Saito, Yoshihiko
    Sakata, Yasushi
    Sato, Naoki
    Seferovic, Petar M.
    Teerlink, John
    Yamamoto, Kazuhiro
    Yoshimura, Michihiro
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (05) : 787 - 804